Preprint · CC-BY
via bioRxiv
Single-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses.
Chaudhary, S., Sravya, M., Pahwa, F., V, S., Singh, P., Chaturvedi, S., Mohanty, D., Dash, D., Nanda, R.
biorxiv · 2025
Abstract
Understanding the perturbed lung immune cells distribution and its functionality in tuberculosis (TB) is well documented; however, limited reports have covered their disruption, if any, in diabetes-tuberculosis (DM-TB) comorbid conditions. Here, we employed single-cell RNA-seq to investigate the molecular mechanisms that govern the heterogeneity in host immune response in DM-TB comorbid conditions. Diabetes is associated with chronic hyperinflammation and reduced lung-infiltrating immune cells, which delays the immune response to Mycobacterial infection. scRNA-seq of lung CD3 and CD11c cells revealed compromised adaptive and innate immunity, with decreased Th1 and M1 macrophage populations in DM-TB mice. A dampened immune response, marked by increased IL-16 signaling and reduced TNF and IFN-II responses, was observed in DM-TB. This study highlights chronic inflammation, hyperglycemia, and dyslipidemia associated with diabetes impairing anti-TB immunity. Selective inhibition of aberrant IL-16 secretion and Th17 cell activation might provide strategies for better managing DM-TB comorbidity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- bioRxiv
- DOI
- 10.1101/2024.10.24.619799
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
S., C., M., S., F., P., S., V., P., S., S., C., D., M., D., D., & R., N. (2025). Single-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses. <em>biorxiv</em>. https://doi.org/10.1101/2024.10.24.619799
Vancouver
S. C, M. S, F. P, S. V, P. S, S. C, et al. Single-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses. biorxiv. 2025. doi:10.1101/2024.10.24.619799.
BibTeX
@unpublished{chaudhary2025Single,
title = {Single-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses.},
author = {Chaudhary, S. and Sravya, M. and Pahwa, F. and V, S. and Singh, P. and Chaturvedi, S. and Mohanty, D. and Dash, D. and Nanda, R.},
journal = {biorxiv},
year = {2025},
doi = {10.1101/2024.10.24.619799},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Immunity & Ageing 2024
Open access · CC-BY
The role of NLRP3 inflammasome in aging and age-related diseases
bioRxiv (Cold Spring Harbor Laboratory) 2025
Preprint · CC-BY
Fibroblast orchestration of inflammaging via NF-kB activation
Gut Microbes 2023
Open access · CC-BY
The impact of aging-induced gut microbiome dysbiosis on dendritic cells and lung diseases
Frontiers in Genetics 2016
Open access · CC-BY
DNA Damage Response and Immune Defense: Links and Mechanisms
Frontiers in Immunology 2022
Open access · CC-BY
Influence of nutrients and metabolites on the differentiation of plasma cells and implications for autoimmunity
Frontiers in Immunology 2024
Open access · CC-BY